Pulmonary sarcoidosis
MONDO:0001708Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Also known as: lung sarcoidosis, sarcoidosis of lung
89 clinical trials for this condition and its sub-types, 20 tagged with Pulmonary sarcoidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug namilumab tested for lung sarcoidosis – but trial halted early
Disease control Stopped earlyThis study tested namilumab, an experimental drug, in 107 people with chronic pulmonary sarcoidosis, a condition causing lung inflammation. The trial was randomized and placebo-controlled, but it was terminated early. The goal was to see if namilumab could reduce the need for res…
Phase 2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control
Last updated Jun 26, 2026 15:32 UTC
-
Sarcoidosis drug study halted after only 2 patients enrolled
Symptom relief Stopped earlyThis study tested whether Acthar gel could improve symptoms and lung function in people with sarcoidosis, a disease that causes inflammation in the lungs. Researchers also checked if a blood marker called CXCL9 could predict how well the treatment works. Only 2 people joined befo…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:27 UTC